Literature DB >> 6416697

Bladder cancer chemotherapy studies supported by the National Bladder Cancer Project.

G H Friedell.   

Abstract

The collaborative group chemotherapy studies of the National Bladder Cancer Project are summarized with regard to intravesical and systemic agents. The necessity for longitudinal observations and data collection in all cases of bladder cancer, and not just those receiving chemotherapy, is also stressed.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6416697

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


  5 in total

1.  Cytology and histopathology of bladder cancer cases in a prospective longitudinal study. National Bladder Cancer Collaborative Group A.

Authors: 
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

2.  SEM on bladder cells.

Authors:  J B Jacobs; S M Cohen; M Arai; G H Friedell
Journal:  Acta Cytol       Date:  1977 Jan-Feb       Impact factor: 2.319

3.  The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.

Authors:  W W Koontz; G R Prout; W Smith; W J Frable; J E Minnis
Journal:  J Urol       Date:  1981-03       Impact factor: 7.450

4.  The pathology of human bladder cancer.

Authors:  G H Friedell; G C Parija; G K Nagy; E A Soto
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

5.  Development of a strategy for a longitudinal study of patients with bladder cancer. National Bladder Cancer Collaborative Group A (NBCCGA).

Authors: 
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.